The independent source for health policy research, polling, and news.
7,081 - 7,100 of 15,453 Results
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
The state branded its Medicaid expansion with some key conservative policies, and officials and advocates across the country are keenly watching the results.
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo and Julie Appleby and Sarah Jane Tribble of Kaiser Health News discuss President Donald Trump’s promises to reduce drug prices in his first State of the Union Address. The panelists also discuss the departure of the director of the Centers for Disease Control and Prevention after conflict-of-interest reports and the efforts by some states to flout the Affordable Care Act.
Some mothers who smoke pot see it as a harmless remedy for everything from pain to postpartum depression. But doctors say the active ingredients in marijuana can be passed onto the baby and may affect developing nervous systems.
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?
While the federal health law made insurers cover the full cost of screening colonoscopies, consumers with a history of polyps who need more frequent tests may have to pick up some costs.
Many eyes are on the Trump administration to see how officials respond to Idaho’s approach to health insurance, which flouts some aspects of the Affordable Care Act.
For more than 50 years, the program for the poor and sick has been required to ferry certain clients to and from medical appointments. But a few states have sought — and received — waivers to that rule.
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Popular DNA ancestry tests don't always find what people expect. That's because of how DNA rearranges itself when egg meets sperm — and the quirks of genetic databases.
California’s family leave program allows people to get time off to care for a new child or sick relative. The wage replacement rate rises this year.
Health care professionals increasingly collaborate with anti-abuse advocates to identify victims and ensure they get the help they need. One women’s center is opening a shelter on the campus of a large public hospital in Los Angeles.
Will efforts to expand the practice to Massachusetts, New York, New Jersey and Hawaii succeed this year?
Philadelphia officials gave the OK to establishing safe-injection sites for drug users. But it's unclear where the sites would be located and who would fund and operate them.
The economy and jobs tend to eclipse health care as the top voter concern in competitive congressional and gubernatorial races.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Paige Winfield Cunningham of The Washington Post discuss the short-term spending bill passed by Congress that reopened the federal government and funded the Children’s Health Insurance Program for six years. The panelists also discussed the health programs still awaiting funding, and the intersection of religion and women’s health services at the Department of Health and Human Services.
The Children's Health Insurance Program drew bipartisan support for two decades. After brinkmanship over the federal budget, an agreement to end the shutdown has assured CHIP funding for six years.
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.
Some hospitals now focus on preparing seniors for the risks and realities of surgical care.
© 2026 KFF